Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Pan Cardiomyopathy Panel (62 Genes) Laboratory for Molecular Medicine Mass General Brigham Personalized Medicine United States | 100 | 61 |
|
MYL3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Cardiomyopathy, hypertrophic, 8, 608751 (MYL3 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 409 | 164 |
|
Ambry Genetics United States | 58 | 30 |
|
Ambry Genetics United States | 58 | 30 |
|
Ambry Genetics United States | 236 | 167 |
|
Ambry Genetics United States | 138 | 56 |
|
Ambry Genetics United States | 189 | 92 |
|
PreventionGenetics, part of Exact Sciences United States | 112 | 111 |
|
Hypertrophic Cardiomyopathy Panel PreventionGenetics, part of Exact Sciences United States | 67 | 64 |
|
PreventionGenetics, part of Exact Sciences United States | 63 | 49 |
|
Comprehensive Cardiology Panel PreventionGenetics, part of Exact Sciences United States | 223 | 201 |
|
Invitae Cardiomyopathy Comprehensive Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 198 | 82 |
|
Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 239 | 100 |
|
Invitae Hypertrophic Cardiomyopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 69 | 30 |
|
Hypertrophic Cardiomyopathy via the MYL3 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Cardiomyopathy, familial hypertrophic 8 (sequence analysis of MYL3 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.